Literature DB >> 7022211

Oral contraceptives and cardiovascular disease (second of two parts).

B V Stadel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7022211     DOI: 10.1056/NEJM198109173051205

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Acute myocardial infarction with "normal" coronary arteries: clinical and angiographic profiles, with ergonovine testing.

Authors:  B I Salem; M Haikal; A Zambrano; A Bollis; S Gowda
Journal:  Tex Heart Inst J       Date:  1985-03

2.  Evaluation of a prescription based record-linkage model for epidemiological studies of long-term adverse effects of drugs--with special regard to combined oral contraceptives.

Authors:  I Persson; H O Adami; S E Norell; B Westerholm; B E Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Postoperative thromboembolic disease and oral contraceptives.

Authors:  N Puttick; M Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-08

4.  Oral contraceptives and thromboembolic disease.

Authors:  S V Pizzo
Journal:  West J Med       Date:  1986-09

5.  Intestinal ischemia and infarction associated with oral contraceptives.

Authors:  D J Schneiderman; J P Cello
Journal:  West J Med       Date:  1986-09

6.  Surgery and the pill.

Authors:  J Guillebaud
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-24

Review 7.  Oestrogens and cardiovascular disease.

Authors:  R Beaglehole
Journal:  BMJ       Date:  1988-09-03

8.  Oral contraceptives and cardiovascular disease: some questions and answers.

Authors:  M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-27

9.  Transdermal dual-controlled delivery of contraceptive drugs: formulation development, in vitro and in vivo evaluations, and clinical performance.

Authors:  Y W Chien; T Y Chien; R E Bagdon; Y C Huang; R H Bierman
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

10.  Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.

Authors:  P Quehenberger; S Kapiotis; C Pärtan; B Schneider; R Wenzel; A Gaiger; W Speiser
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.